Repurposing Drugs as Bacteroides fragilis BFT‐3 Inhibitors in the Animal Infection Model Galleria mellonella
Annals of the New York Academy of Sciences · 2026-03 · 1557 (1)
DOI: 10.1111/nyas.70255 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the New York Academy of Sciences, online erschienen am 23.03.2026. Verfasst von Ana Jiménez-Alesanco und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biocomputation and Physics of Complex Systems (BIFI), Universidad de Zaragoza, Zaragoza, Spain. Hauptthemen laut MEDLINE: Bacteroides fragilis, Drug Repositioning, Metalloendopeptidases, Anti-Bacterial Agents. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Gobierno de Aragón, Instituto de Salud Carlos III.
Abstract (Originalsprache)
Bacteroides fragilis is a key component of the human gut microbiota, although enterotoxigenic strains (ETBF), which produce B. fragilis toxin (BFT), can act as opportunistic pathogens. BFT disrupts intestinal epithelial integrity and contributes to conditions such as inflammatory bowel disease and colorectal cancer. This study aimed to characterize three allosteric inhibitors of BFT‐3 (isoform 3 of BFT), previously identified by our group through high‐throughput screening of US Food and Drug Administration approved drugs. We evaluated their activities in vitro and in vivo. Using Galleria mellonella larvae as a novel infection model for B. fragilis , we assessed the antimicrobial and antivirulence potential of these compounds. Among the three tested compounds, MOA4 demonstrated superior efficacy, enhanced bacterial clearance in vivo, and increased larval survival in a dose‐dependent manner, with minimal toxicity. Synergy studies have revealed the potential combinatory effects of MOA4 and conventional antibiotics. These findings establish G. mellonella as a valuable alternative model for studying B. fragilis infections and highlight MOA4 as a promising candidate to be repurposed for the treatment of B. fragilis ‐mediated diseases while preserving commensal microbiota.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biocomputation and Physics of Complex Systems (BIFI), Universidad de Zaragoza, Zaragoza, Spain.
- Departamento de Microbiología, Facultad de Medicina, Universidad de Zaragoza, Zaragoza, Spain.
- Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain.
- Departamento de Bioquímica y Biología Molecular y Celular, Universidad de Zaragoza, Zaragoza, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
Förderung
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
- Gobierno de Aragón
- Instituto de Salud Carlos III
- Ministerio de Ciencia e Innovación
- Ministerio de Economía y Competitividad
- Ministerio de Ciencia, Innovación y Universidades
Zitieren
APA
Jiménez-Alesanco, A., Gómara-Lomero, M., Jeblaoui, H., Vega, S., Velázquez-Campoy, A., Aínsa, J. A., & Abián, O. (2026). Repurposing Drugs as Bacteroides fragilis BFT‐3 Inhibitors in the Animal Infection Model Galleria mellonella. Annals of the New York Academy of Sciences, 1557(1). https://doi.org/10.1111/nyas.70255
Vancouver
Jiménez-Alesanco A, Gómara-Lomero M, Jeblaoui H, Vega S, Velázquez-Campoy A, Aínsa JA, et al. Repurposing Drugs as Bacteroides fragilis BFT‐3 Inhibitors in the Animal Infection Model Galleria mellonella. Annals of the New York Academy of Sciences. 2026;1557(1). doi:10.1111/nyas.70255
BibTeX
@article{JimnezAlesanco2026,
author = {Jiménez-Alesanco, Ana and Gómara-Lomero, Marta and Jeblaoui, Hajar and Vega, Sonia and Velázquez-Campoy, Adrián and Aínsa, José Antonio and Abián, Olga},
title = {Repurposing Drugs as Bacteroides fragilis BFT‐3 Inhibitors in the Animal Infection Model Galleria mellonella},
journal = {Annals of the New York Academy of Sciences},
year = {2026},
volume = {1557},
number = {1},
doi = {10.1111/nyas.70255}
}
EUVIMED